BioRestorative Therapies (BRTX) Gross Margin (2012 - 2026)
BioRestorative Therapies (BRTX) reported Gross Margin of 68.13% for Q1 2026, down 20.24 percentage points from 88.36% a year earlier and down 23.53 percentage points from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Gross Margin (2012 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, BioRestorative Therapies' Gross Margin came in at 92.09%, up 0.01 percentage points year-over-year; for FY2025, it was 93.37%, up 0.37 percentage points from FY2024.
- By year, Gross Margin came in at 93.00% in FY2024 (-7.00 pp) and 100.00% in FY2023.
- Five-year quarterly Gross Margin spans a low of 10.42% in Q3 2025 and a high of 100.00% in Q1 2024.
- Year over year, Gross Margin has now declined in each of the last three quarters, with an average year-over-year change of -16.58 percentage points over the last eight quarters.
- The high point for year-over-year Gross Margin in five years was Q2 2025 (a gain of 4.41 percentage points); the low point was Q3 2025 (a drop of 81.77 percentage points).
- Per Business Quant data, the three quarters before Q1 2026 came in at 91.65% (Q4 2025), 10.42% (Q3 2025) and 97.12% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | 68.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 68.13% |
| Dec 31, 2025 | 91.65% |
| Sep 30, 2025 | 10.42% |
| Jun 30, 2025 | 97.12% |
| Mar 31, 2025 | 88.36% |
| Dec 31, 2024 | 92.29% |
| Sep 30, 2024 | 92.19% |
| Jun 30, 2024 | 92.72% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 100.00% |
| Dec 31, 2017 | 100.00% |
| Sep 30, 2017 | 100.00% |
| Jun 30, 2017 | 100.00% |
| Mar 31, 2017 | 100.00% |
| Dec 31, 2016 | 99.65% |
| Sep 30, 2016 | 100.00% |
| Jun 30, 2016 | 99.56% |
| Mar 31, 2016 | 99.89% |
API Access
BioRestorative Therapies Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();